0001140361-16-079736.txt : 20160914 0001140361-16-079736.hdr.sgml : 20160914 20160914110251 ACCESSION NUMBER: 0001140361-16-079736 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160914 DATE AS OF CHANGE: 20160914 EFFECTIVENESS DATE: 20160914 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Revitope Oncology, Inc. CENTRAL INDEX KEY: 0001667518 IRS NUMBER: 811138303 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-257799 FILM NUMBER: 161884437 BUSINESS ADDRESS: STREET 1: 676 CLIPPER STREET, #2 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 BUSINESS PHONE: (415) 710-6702 MAIL ADDRESS: STREET 1: 676 CLIPPER STREET, #2 CITY: SAN FRANCISCO STATE: CA ZIP: 94114 D/A 1 primary_doc.xml X0707 D/A LIVE 0001667518 Revitope Oncology, Inc. 953 Indiana St SAN FRANCISCO CA CALIFORNIA 94107 (415) 710-6702 DELAWARE None None Corporation true 2016 Julie Cherrington c/o Revitope Oncology, Inc. 953 Indiana St San Francisco CA CALIFORNIA 94107 Executive Officer Director Andrew Allen c/o Revitope Oncology, Inc. 953 Indiana St San Francisco CA CALIFORNIA 94107 Executive Officer Director Peter Joost c/o Revitope Oncology, Inc. 953 Indiana St San Francisco CA CALIFORNIA 94107 Director Mark Cobbold c/o Revitope Oncology, Inc. 953 Indiana St San Francisco CA CALIFORNIA 94107 Director Raj Mehta c/o Revitope Oncology, Inc. 953 Indiana St San Francisco CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b true 0001140361-16-054109 2016-02-10 false true false 0 8200000 8200000 0 false 12 0 0 0 false Revitope Oncology, Inc. /s/ Julie Cherrington Julie Cherrington President and Chief Executive Officer 2016-09-14